Seminar Detail

2-Day: Psychopharmacology Conference for Today's Mental Health Professional: "Must Have" Information to Better Serve Your Clients
2-Day: Psychopharmacology Conference for Today's Mental Health Professional: "Must Have" Information to Better Serve Your Clients

Where:   CINCINNATI, OH

When:  Thursday, November 21, 2019 - Friday, November 22, 2019

This event is no longer available for purchase.
Details

$499.99
Single Registration
$439.99
2+ Group Rate: per person
*** All prices are shown in US Dollars ***
 
View brochure for CE details
Location

KINGSGATE CONFERENCE CENTER
151 GOODMAN DRIVE
CINCINNATI, OH 45219
Phone:  513-487-3800
View Map

Student Discounts
If you are a student, please click here for registration information.

Group Discounts
If 5+ staff members from your facility are attending this event, please call (800) 844-8260 to learn more about our special rates.

Military Discount
If you are active or retired military personnel, please click here for registration information and select the Military tab.

In-House Options
If you would like this educational event brought to your facility, please click here for on-site training options.

Course Description:

Spend two action-packed days learning about the newest advances in psychopharmacology and contemporary trends in medication management. From her unique perspective, Sharon Freeman Clevenger, MSN, MA, PMHCNS-BC, CARN-AP teaches psychopharmacology thoughtfully, with an emphasis on the experience of the client. Sharon’s years of experience in mental health and passion for clients shines through in the detail and thoroughness of her presentation.

Clients often only have a few minutes with their prescriber and require additional support. It’s vital that you are able to answer their questions, help manage side effects and understand reactions. Designed for counselors, nurses, psychotherapists, psychologists, and other mental health professionals, Sharon provides the information you need in order to best help your clients.

This conference allows time for exploration of underrepresented areas, including ADHD, sleep, eating, and substance use disorders. Take home specialized guidelines for geriatrics, pregnant or nursing women, and clients with chronic pain. Discuss how the DSM-5® has impacted prescribing patterns and the use of psychotropics in newly defined diagnoses. In addition to a general ‘nuts and bolts’ review of medications, you will examine case examples, discuss medication controversies and how to effectively collaborate with prescribing practitioners.

Sharon’s engaging presentation includes many take home “pearls” you can use to teach your clients about their medications and how to protect them from concerning, dangerous or adverse effects. As a bonus, Sharon will discuss alternative approaches using nutrition, supplements, vitamins and essential oils. Increase your understanding about complementary alternative medications such as supplements and essential oils including expected effects, side effects and interaction effects with prescribed medications. You will find this conference to have the most up to date medication information and how to use it most effectively with your client.
Objectives:

DAY 1
  1. Specify how psychotropic medications are chosen for mood disorders and specific patient characteristics.
  2. Analyze the actions, therapeutic uses, and side effects of antidepressants.
  3. Assist clients in overcoming barriers that impede the efficacy of their medication regime.
  4. Determine options for clients with treatment resistant mood disorders.
  5. Communicate the actions, side effects, and therapeutic uses of antipsychotic medications.
  6. Evaluate the three critical strategies for improving collaboration with prescribing practitioners.


DAY 2
  1. Explore psychotropic medication treatment options for clients with Attention Deficit/Hyperactivity Disorder.
  2. Articulate the efficacy of psychotropic medications in treating eating disorders and discuss how to integrate psychotherapy with psychopharmacology for successful treatment outcomes.
  3. Formulate medication treatment options for substance use disorders and discuss how to effectively incorporate medication assisted treatments into an overall plan for care.
  4. Analyze the interaction between women’s hormone levels and their mental health symptoms.
  5. Explore the use of complementary and alternative agents for treatment of mental illnesses.
  6. Determine the unique medication treatment considerations for geriatric clients.

OUTLINE

DAY 1

PSYCHOPHARMACOLOGY
  • Drug metabolism concepts
  • Drug mechanisms of action – what we know, what we don’t know
  • Placebo effects – power & how to get it to work for your client
  • When to refer for medication – pearls for increasing client interest and participation
  • Developing highly effective collaborations with prescribers
DEPRESSIVE DISORDERS
  • Neurochemistry of depression
  • Controversy regarding antidepressants and placebo – Who to treat when?
  • Types of antidepressants – pearls and pitfalls of different agents
  • Managing side effects
  • Treatment Resistant depression and drug combinations
ANXIETY DISORDERS & OBSESSIVE COMPULSIVE DISORDERS & TRAUMA RELATED DISORDERS
  • Neurochemistry of anxiety
  • SGAD, panic disorder, phobias
  • OCD
  • PTSD
  • Physiological interventions
  • Anti-anxiety medications
    • Antidepressants
    • The many other options often ignored
  • Benzodiazepines: risks and benefits
    • How to recognize problematic prescribing patterns
    • Getting off benzos: key pearls for success
  • Managing side effects
BIPOLAR DISORDERS
  • Neurochemistry and symptoms
  • The Bipolar Spectrum concept & DSM-5® changes
  • Types of mood stabilizers, when to use which and potential adverse effects
    • Lithium
    • Anticonvulsants
    • Atypical antipsychotics
    • Augmenting agents
  • Effective strategies for improving outcomes for clients
    • Using blood levels effectively – what the prescriber may not be watching
  • Treating pregnant or potentially pregnant women with bipolar disorder
PSYCHOTIC DISORDERS/SCHIZOPHRENIA
  • Neurochemistry of psychosis and schizophrenia
    • Antipsychotic Medications:
      • First generation (typical)
      • Second generation (atypical)
    • Managing side effects
      • Extrapyramidal symptoms and TD
      • Metabolic problems – what blood tests are needed and when
      • Preventing Diabetes Mellitus
    • Recognizing hyperprolactinemia – and why you need to know
    • Use of atypical antipsychotics for multiple disorders
    • Pregnancy and psychotic disorders
LIMITATIONS OF THE RESEARCH & POTENTIAL RISKS


DAY 2

ATTENTIONAL DISORDERS
  • Differential diagnosis
  • Neurochemistry of ADHD
  • Controversy about treatment of ADHD with stimulants
  • Substance abuse and ADHD
  • Stimulant medications
  • Non-stimulant options
  • Managing side effects
SLEEP DISORDERS
  • Sleep disorders
  • Differential diagnosis
  • Chicken or the egg? What came first, sleep problems or mental illness
  • Controversy about treating sleep problems with hypnotics
  • Sleep interventions that really work
  • Hypnotic medications: risks and benefits
  • Alternatives to hypnotics
  • Recognizing adverse Effects
SUBSTANCE USE DISORDERS
  • Neurochemistry of addiction & habit development
  • Drugs of abuse and interaction with psychiatric medications
    • Caffeine
    • Nicotine
  • Marijuana (discussion of medical marijuana, cost vs. benefit>
  • Others
  • Challenging the old thinking about when to prescribe for clients with dual diagnosis-what we now know
  • Medication assisted treatments for addictions
    • Alcohol
    • Nicotine
    • Cannabis
    • Opiates
  • Behavioral addictions – what we know works
EATING DISORDERS
  • Anorexia, bulimia, binge eating disorder
  • Weight gain from psychotropic medications
  • Recognizing medical emergencies
    • Standard of care for lab work
  • Integrating psychotherapy with psychopharmacology
SPECIAL POPULATIONS: GERIATRICS
  • Specialized guidelines for geriatric clients
  • Discussion of dementia treatment
  • Antipsychotic controversy
SPECIAL POPULATIONS: WOMEN
  • Hormonal issues in mood disorders & anxiety
  • Pregnancy and breastfeeding -
    • Presenting the choices
    • Resources for you and your clients
  • The dangerous, the concerning, and the possibly good options for psychopharmacology
  • Menopause – current knowledge and agents
TREATING CLIENTS WITH COMORBID CHRONIC PAIN
  • Neurochemistry implications – why it’s critical to intervene
  • When psychopharmacology can help
  • Other alternative interventions
LIMITATIONS OF THE RESEARCH & POTENTIAL RISKS
Target Audience

  • Counselors
  • Nurses
  • Nurse Practitioners
  • Clinical Nurse Specialists
  • Physician Assistants
  • Psychotherapists
  • Psychologists
  • Social Workers
  • Case Managers
  • Marriage and Family Therapists
  • Addiction Counselors
  • Pharmacists
  • Occupational Therapists
  • Occupational Therapist Assistants
  • School Psychologists
  • Others in caring professions

SHARON M. FREEMAN CLEVENGER, MSN, MA, PMHCNS-BC

Sharon Freeman Clevenger, MSN, MA, PMHCNS-BC, CARN, AP is the founder, psychiatric nurse practitioner, and senior clinical supervisor of the Indiana Center for Cognitive Behavior Therapy in Fort Wayne, Indiana. She has national certification as an Advanced Practice Psychiatric Clinical Nurse Specialist with prescriptive authority, as well as senior level international certification as an Advanced Practice Certified Addiction Nurse through the International Society of Nurses on Addictions. Sharon is former president of NAADAC, the Association for Addiction Professionals.

Sharon has lectured to professional and military/law enforcement audiences worldwide. She has authored more than 50 chapters and articles and has been a guest expert on the TV show, The Doctors. She is the co-editor for both the therapist manual and patient handbook of Overcoming Depression: A Cognitive Behavior Approach (Oxford University Press, 2009), senior editor and author of Living and surviving in Harm’s Way: The Psychological Treatment Manual for Pre-and-Post-Deployment of Military Members (Routledge, 2008), Behind the Badge: A Psychological Treatment Handbook for Law Enforcement Officers (Routledge, 2008), Behind the Badge: A Psychological Treatment Handbook for Law Enforcement Officers (Routledge, 2014), and senior editor and author of Cognitive Behavior Therapy in Nursing Practice (Springer Publishers, 2005).

Sharon has a Master’s degree in Advance Practice Psychiatric Mental Health Nursing from the University of Pennsylvania, and a Master of Arts in Counseling Psychology from the Adler School of Professional Psychology. She is a Doctor of Science candidate in Integrative Healthcare at Huntington University of Health Sciences in Knoxville, TN.



Speaker Disclosures:

Financial: Sharon Freeman Clevenger is Founder and Executive Director of the Indiana Center for Cognitive Behavior Therapy. She receives an honorarium from Allergan. She receives a speaking honorarium from PESI, Inc.

Nonfinancial: Sharon Freeman Clevenger has no relevant nonfinancial relationship to disclose.
Ethics
This seminar includes 3.0 hours of general ethics instruction. If ethics is not specified within your licensing board’s approval statement below, please contact your board to determine the applicability and amount of ethics allowed.


Addiction Counselors
This course has been approved by PESI, Inc., as a NAADAC Approved Education Provider, for 12.5 CE in the Counseling Services skill group. NAADAC Provider #77553. PESI, Inc. is responsible for all aspects of their programming. Full attendance is required; no partial credit will be awarded for partial attendance.

Ohio Chemical Dependency Professionals: This course has been approved by the Ohio Chemical Dependency Professionals Board for 12.5 CEUs.


Counselors
This intermediate activity consists of 12.5 clock hours of continuing education instruction. Credit requirements and approvals vary per state board regulations. Please save the course outline, the certificate of completion you receive from the activity and contact your state board or organization to determine specific filing requirements.

Indiana Counselors: This intermediate activity consists of 12.5 clock hours of continuing education instruction. Credit requirements and approvals vary per state board regulations. Please contact your licensing board to determine if they accept programs or providers approved by other national or state licensing boards. A certificate of attendance will be awarded at the end of the program to participants who are in full attendance and who complete the program evaluation.

Kentucky Counselors: CE credit is available. The Kentucky Board of Licensed Professional Counselors granted approval for this program on 07/23/2019 for 15.0 hours of general continuing education credit for LPCAs and LPCCs per 201 KAR36:030 section 2(1).

Ohio Counselors:
Florida
CE credit is available. PESI, Inc. is an approved provider with the State of Ohio Counselor, Social Worker and Marriage & Family Therapist Board. Provider approval #:RCST071001. Full attendance at this course meets the qualifications for 12.5 clock hours of continuing education credit.


Marriage & Family Therapists
This activity consists of 760 minutes of continuing education instruction. Credit requirements and approvals vary per state board regulations. You should save this course outline, the certificate of completion you receive from the activity and contact your state board or organization to determine specific filing requirements.

Kentucky Marriage & Family Therapists: This course has been approved by the Kentucky Board of Licensure of Marriage & Family Therapists on September 19, 2019 for 15.0 hours of continuing education.

Ohio Marriage & Family Therapists:
Florida
PESI, Inc. is an approved provider with the State of Ohio Counselor, Social Worker and Marriage & Family Therapist Board. Provider approval #:RCST071001. Full attendance at this course meets the qualifications for 12.5 clock hours of continuing education credit.


Nurses, Nurse Practitioners, and Clinical Nurse Specialists
American Nurses Credentialing Center Logo
PESI, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Nurses in full attendance will earn 12.6 contact hours. Partial contact hours will be awarded for partial attendance.


Pharmacology Nurse Practitioners
This program offers 760 instructional minutes of pharmacology content which is designed to qualify for 12.6 contact hours toward your pharmacology requirement to receive credit. It is your responsibility to submit your certificate of successful completion and a copy of the seminar brochure to your licensing board.


Occupational Therapists & Occupational Therapy Assistants
AOTA Logo
PESI, Inc. is an AOTA Approved Provider of continuing education. Provider #: 3322. Full attendance at this course qualifies for 12.5 contact hours or 1.25 CEUs in the Category of Domain of OT and Occupational Therapy Process. Partial credit will be issued for partial attendance. The assignment of AOTA CEUs does not imply endorsement of specific course content, products, or clinical procedures by AOTA. Course Level: Intermediate.


Pharmacists
ACPE Logo
PESI, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Successful completion of this Knowledge-based activity qualifies for 12.6 contact hours. ACPE Universal Program Number: 0289-0000-17-005-L01-P. Full attendance is required. No partial contact hours will be awarded for partial attendance. Please note: Pharmacists are required to complete a program evaluation/post-test within two weeks of attending the live event if they would like their participation submitted to ACPE. A valid NABP e-Profile ID and Birthdate (mm/dd) will be required for reporting. Don’t have your e-Profile ID yet? Visit the National Association of Boards of Pharmacy (NABP) website and complete your e-profile at www.nabp.net in order to obtain your NABP e-Profile ID.


Physician Assistants
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by ACCME such as PESI. Physician assistants may receive a maximum of 12.5 hours for completing this program.

PESI, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. PESI, Inc. designates this live activity for a maximum of 12.5 AMA PRA Category 1 Credits™.


Psychologists & Psychiatrists & Physicians
ACCME Logo

Psychiatrists & Physicians
PESI, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. PESI, Inc. designates this live activity for a maximum of 12.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Psychologists
The following state psychologist boards recognize activities sponsored by PESI, Inc. as an approved ACCME provider: Alaska, Arkansas, California, Colorado, Georgia, Illinois, Indiana, Kentucky, Maine, Maryland, Missouri, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, Oklahoma, Pennsylvania, South Carolina and Wisconsin. This activity consists of 12.5 clock hours of continuing education instruction. Certificates of attendance will be issued for you to submit to your state licensing board to recognize for continuing education credit.

Indiana Psychologists: CE credit is available. PESI, Inc is an approved provider with the Indiana Board of Psychology. Certificate #: 98000998A - Category I. PESI maintains full responsibility for this program and its contents. Full attendance at this course qualifies for 12.5 contact hours.

Kentucky Psychologists: CE credit is available. PESI, Inc. is approved by the Kentucky Board of Examiners of Psychology to offer continuing education for psychologists. PESI maintains responsibility for this program and its content. This activity will qualify for 12.5 contact hours.

Ohio Psychologists: CE credit is available. PESI, Inc. is approved by the Ohio Psychological Association, Provider #263896894, to sponsor continuing education for psychologists. PESI, Inc. maintains responsibility for this program and its content. PESI is offering this activity for 12.5 standard hours of continuing education credit. Full attendance is required; no partial credits will be offered for partial attendance.


Social Workers
ASWB Logo
PESI, Inc., #1062, is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved as ACE providers. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. PESI, Inc. maintains responsibility for this course. ACE provider approval period: January 27, 2017 - January 27, 2020. Social Workers completing this course receive 9.5 Clinical Practice and 3.0 Ethics continuing education credits. No more than 12.5 total CE hours may be awarded for this activity. Course Level: Intermediate. Full attendance is required; no partial credits will be offered for partial attendance. A certificate of attendance will be awarded at the end of the program to social workers who complete the program evaluation.

Ohio Social Workers:
Florida
PESI, Inc. is an approved provider with the State of Ohio Counselor, Social Worker and Marriage & Family Therapist Board. Provider approval #:RCST071001. Full attendance at this course meets the qualifications for 12.5 clock hours of continuing education credit.


Other Professions
This activity qualifies for 760 minutes of instructional content as required by many national, state and local licensing boards and professional organizations. Save your course outline and certificate of completion, and contact your own board or organization for specific requirements.

Credit Card Required for online registration | Contact us to redeem Gift Certificates